---
title: HB 473. Controlled substances; Schedule I; provide certain provisions
collection: bills
id: 2025-2026/hb473
cite_as: HB 473, 2025-2026 Regular Session (Ga.)
canonical_url: https://georgiacommons.org/bills/2025-2026/hb473
md_url: https://georgiacommons.org/bills/2025-2026/hb473.md
text_url: https://georgiacommons.org/bills/2025-2026/hb473/text
source_url: https://www.legis.ga.gov/legislation/70390
date: 2025-05-01
status: passed
corpus_version: bills-2026-08-28
license: Public record of the Georgia General Assembly, via LegiScan; see about.md
publisher: Georgia Commons, an independent project of Georgia Civic Data. Not the State of Georgia. Not legal advice.
up: https://georgiacommons.org/bills/2025-2026.md
previous: https://georgiacommons.org/bills/2025-2026/hb472.md
next: https://georgiacommons.org/bills/2025-2026/hb474.md
index: https://georgiacommons.org/bills/index.md
omitted: votes and history
omitted_chars: 946
omitted_url: https://georgiacommons.org/bills/2025-2026/hb473.md?full=1
bill_number: HB 473
session: 2025-2026 Regular Session
session_slug: 2025-2026
chamber: House
bill_type: bill
status_date: 2025-05-01
last_action: Effective Date 2025-05-01
sponsors:
  - Ron Stephens
  - Lee Hawkins
  - Mark Newton
  - Ben Watson
text_version: Enrolled
has_text: true
legiscan_url: https://legiscan.com/GA/bill/HB473/2025
upstream_id: 1974411
summaries_model: claude-sonnet-5
topic_tags:
  - controlled substances
  - drug scheduling
  - pharmacy regulation
  - dangerous drugs list
---

# HB 473. Controlled substances; Schedule I; provide certain provisions

## Text

25 LC 48 1480/AP
House Bill 473 (AS PASSED HOUSE AND SENATE)
By: Representatives Stephens of the 164th, Hawkins of the 27th, and Newton of the 127th
A BILL TO BE ENTITLED
AN ACT
To amend Chapter 13 of Title 16 of the Official Code of Georgia Annotated, relating to1
controlled substances, so as to provide for certain provisions relating to Schedule I controlled2
substances; to provide for certain provisions relating to the definition of dangerous drugs; to3
provide for related matters; to provide for an effective date; to repeal conflicting laws; and4
for other purposes.5
BE IT ENACTED BY THE GENERAL ASSEMBLY OF GEORGIA:6
SECTION 1.7
Chapter 13 of Title 16 of the Official Code of Georgia Annotate d, relating to controlled8
substances, is amended in Code Section 16-13-25, relating to Sc hedule I controlled9
substances, by revising subparagraph (TT) of paragraph (1) as follows:10
"(TT) Methyl 2-methyl-AP-237;"11
SECTION 2.12
Said chapter is further amended in Code Section 16-13-25, relating to Schedule I controlled13
substances, by revising subparagraph (CC) of paragraph (3) as follows:14
"(CC) Acetylpsilocin (4-acetoxy-N,N-dimethyltryptamine, 4-AcO-DMT); Reserved;"15
H. B. 473
- 1 -
25 LC 48 1480/AP
SECTION 3.16
Said chapter is further amended in Code Section 16-13-25, relating to Schedule I controlled17
substances, by adding a new subparagraph to paragraph (4) to read as follows:18
"(A.5) Ethylphenidate;"19
SECTION 4.20
Said chapter is further amended in Code Section 16-13-25, relating to Schedule I controlled21
substances, by adding a new subdivision to division (13)(E)(ii) to read as follows:22
"(III) Tetrahydrothiophene group;"23
SECTION 5.24
Said chapter is further amended in Code Section 16-13-71, relat ing to dangerous drug, by25
adding new paragraphs to subsection (b) to read as follows:26
"(12.8) Acoramidis;"27
"(17.07) Afamitresgene autoleucel;"28
"(62.45) Aprocitentan;"29
"(63.3) Arimoclomol;"30
"(68.133) Atidarsagene autotemcel;"31
"(69.23) Axatilimab-csfr;"32
"(153.65) Ceftobiprole medocaril sodium;"33
"(206.6) Coagulation Factor IX (recombinant);"34
"(213.2) Concizumab-mtci;"35
"(216.5) Cosibelimab-ipdl;"36
"(217.3) Crinecerfont;"37
"(220.5) Crovalimab-akkz;"38
"(238.5) Danicopan;"39
"(256.58) Deuruxolitinib;"40
H. B. 473
- 2 -
25 LC 48 1480/AP
"(256.8) Deutivacaftor;"41
"(316.45) Donanemab-azbt;"42
"(331.0504) Eladocagene exuparvovec-tneq;43
(331.0506) Elafibranor;"44
"(331.0515) Elaparvovec-dzkt;"45
"(332.3) Enmetazobactam;"46
"(332.73) Ensartinib;47
(332.75) Ensifentrine;"48
"(380.45) Exagamglogene autotemcel;"49
"(402.3) Flurpiridaz F 18;"50
"(415.005) Givinostat;"51
"(464.9) Imetelstat;"52
"(466.8) Immune globulin, Human;"53
"(469.02) Inavolisib;"54
"(487.09) Iomeprol;"55
"(512.1) Landiolol;"56
"(513.03) Lazertinib;57
(513.07) Lebrikizumab-lbkz;"58
"(513.79) LetibotulinumtoxinA-wlbg;"59
"(514.3) Levacetylleucine;"60
"(520.1) Lifileucel;"61
"(530.3) Lovotibeglogene autotemcel;"62
"(540.47) Marstacimab-hncq;"63
"(540.8) Mavorixafor;"64
"(638.9) Nemolizumab-ilto;"65
"(649) Nogapendekin alfa inbakicept-pmln;"66
"(661.02) Obecabtagene autoleucel;"67
H. B. 473
- 3 -
25 LC 48 1480/AP
"(663.03) Olezarsen;"68
"(681.55) Palopegteriparatide;"69
"(692.5175) Pegulicianine;"70
"(835.7) Resmetirom;"71
"(836.75) Revumenib;"72
"(852.55) Seladelpar;"73
"(860.5) Smallpox and mpox (vaccinia) vaccine;"74
"(881.04) Sofpironium;"75
"(883.55) Sotatercept-csrk;"76
"(927.3) Sulopenem etzadroxil;"77
"(931.17) Tarlatamab-dlle;"78
"(967.625) Tislelizumab-jsgr;"79
"(973.55) Tovorafenib;"80
"(1021.65) Vadadustat;"81
"(1025.3) Vanzacaftor;"82
"(1037.4) Vorasidenib;"83
"(1039.05) Xanomeline;"84
"(1042.035) Zanidatamab-hrii;"85
"(1042.047) Zenocutuzumab-zbco;"86
"(1042.79) Zolbetuximab-clzb;"87
SECTION 6.88
Said chapter is further amended in Code Section 16-13-71, relat ing to dangerous drug, by89
adding a new subparagraph to paragraph (59) of subsection (b) to read as follows:90
"(ZZ.5) Peanut (arachis hypogaea) allergen powder-dnfp;"91
H. B. 473
- 4 -
25 LC 48 1480/AP
SECTION 7.92
This Act shall become effective upon its approval by the Governor or upon its becoming law93
without such approval.94
SECTION 8.95
All laws and parts of laws in conflict with this Act are repealed.96
H. B. 473
- 5 -

## Summaries written by Georgia Commons

The following was written by claude-sonnet-5 from the text above and is not part of the bill. Quote the text, not the summary.

House Bill 473 updates Georgia's controlled substances and dangerous drug lists, adjusting which chemical compounds count as Schedule I drugs and adding dozens of newly approved medications to the state's dangerous drug list.

### Plain-language summary

Georgia law keeps detailed lists of controlled substances and dangerous drugs in O.C.G.A. Chapter 13 of Title 16. This bill makes technical updates to those lists. It revises the name of one Schedule I substance, removes acetylpsilocin from the Schedule I list by marking its entry as reserved, and adds a new Schedule I substance called ethylphenidate along with a new chemical group classification.
The bill also adds a long list of newly identified pharmaceutical products, mostly recently approved drugs and biologics with technical names, to the state's definition of dangerous drugs under O.C.G.A. § 16-13-71. This keeps Georgia's dangerous drug list current with drugs that require a prescription. The changes would take effect immediately once the Governor signs the bill or it becomes law without a signature.

### What it does

- Rewrites the listing for one Schedule I controlled substance in O.C.G.A. § 16-13-25, changing its chemical name entry.
- Removes acetylpsilocin as a Schedule I substance by marking its former entry as reserved rather than active.
- Adds ethylphenidate as a new Schedule I controlled substance under Georgia law.
- Adds a new chemical subgroup, the tetrahydrothiophene group, to the Schedule I substance classifications.
- Adds roughly 60 newly named pharmaceutical drugs and biologics to Georgia's dangerous drug list under O.C.G.A. § 16-13-71.
- Adds peanut allergen powder to the dangerous drug list as a distinct new entry.

### Who it affects

Pharmacists, physicians, and other health care providers who prescribe or dispense the newly listed drugs, law enforcement and prosecutors who classify controlled substances, and patients who use the newly added prescription medications or peanut allergen treatment products.

### Why it matters

Keeping these lists current affects how pharmacies dispense certain medications, how law enforcement treats possession of newly listed or delisted substances, and which prescription rules apply to dozens of recently approved drugs, including a peanut allergy treatment product.

### Key provisions

- Section 1 revises the Schedule I listing for Methyl 2-methyl-AP-237 under O.C.G.A. § 16-13-25.
- Section 2 marks acetylpsilocin's Schedule I entry as 'Reserved,' effectively removing it from active listing.
- Section 3 adds ethylphenidate as a new Schedule I controlled substance.
- Section 4 adds the tetrahydrothiophene group as a new chemical subdivision under Schedule I classifications.
- Section 5 adds around 60 newly named drugs, including cancer treatments, vaccines, and other therapeutics, to the dangerous drug list under O.C.G.A. § 16-13-71.
- Section 6 adds peanut (arachis hypogaea) allergen powder as a new dangerous drug entry.
- Section 7 makes the law effective immediately upon the Governor's signature or upon becoming law without signature.

## Status

- Status: Passed (2025-05-01)
- Last action: Effective Date 2025-05-01 (2025-05-01)
- Sponsors: Ron Stephens, Lee Hawkins, Mark Newton, Ben Watson
- Official page: https://www.legis.ga.gov/legislation/70390

> The history, votes, and amendments (946 characters) are at https://georgiacommons.org/bills/2025-2026/hb473.md?full=1